Skip to main content
. 2025 Apr 14;47(3):932–940. doi: 10.1007/s00246-025-03859-9

Table 2.

Subgroup analysis according to baseline presence of diarrhea

Variables Diarrhea group No Diarrhea group p-value
N 7 8
Age, years 16.0 (14.0 ~ 21.0) 12.5 (10.3 ~ 22.0) 0.463
Gender (M/F) 5/2 3/5 0.315
Baseline body weight, kg 35.5 (32.5 ~ 44.1) 39.2 (29.1 ~ 46.2) 0.779
Time interval OP to PLE diagnosis, years 2.5 (1.2 ~ 8.1) 2.2 (0.6 ~ 7.0) 0.535
Baseline symptoms
 Stool number (median, IQR) 3.5 (3.5 ~ 4.25) 1.5 (1.0 ~ 2.25) 0.009
 Edema, N (%) 4/7 (57.1%) 3/8 (37.5%) 0.619
 Ascites, N (%) 5/7 (71.4%) 5/8 (62.5%) 1.000
Laboratory results
 Serum albumin
  Baseline (median, IQR), g/dL 1.8 (1.7 ~ 2.1) 2.7 (2.1 ~ 3.5) 0.076
  6 month f/u (median, IQR), g/dL 2.4 (2.3 ~ 3.3) 2.6 (2.5 ~ 3.4) 0.573
  Endpoint (median, IQR), g/dL 2.2 (2.0 ~ 3.1) 2.6 (2.2 ~ 3.3) 0.613
 Stool alpha-1 antitrypsin
  Baseline (median, IQR), mg/dL 220.3 (176.2 ~ 486.5) 194.1 (56.7 ~ 344.3) 0.559
  6 month f/u (median, IQR), mg/dL 75.5 (27.3 ~ 230.7) 66.2 (40.7 ~ 210.9) 0.836
  Endpoint (median, IQR), mg/dL 100.3 (38.8 ~ 132.1) 275.0 (165.3 ~ 396.6) 0.041

Values are number or median, Interquartile range